Prevalence of rheumatoid arthritis in Germany based on health insurance data. Regional differences and first results of the PROCLAIR study

被引:42
作者
Hense, S. [1 ,2 ]
Ramos, A. Luque [1 ]
Callhoff, J. [3 ]
Albrecht, K. [3 ]
Zink, A. [3 ,4 ]
Hoffmann, F. [1 ]
机构
[1] Carl von Ossietzky Univ Oldenburg, Dept Versorgungsforsch, Fak Med & Gesundheitswissensch, Ammerlander Heerstr 140, D-26111 Oldenburg, Germany
[2] Robert Koch Inst, Abt Epidemiol & Gesundheitsmonitoring, Berlin, Germany
[3] Deutsch Rheumaforschungszentrum Berlin, Programmbereich Epidemiol, Berlin, Germany
[4] Charite, Klin Schwerpunkt Rheumatol & Klin Immunol, Berlin, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2016年 / 75卷 / 08期
关键词
Rheumatoid arthritis; Epidemiology; Secondary data; Health services research; Healthcare insurance data; VALIDATION; SMOKING; RISK;
D O I
10.1007/s00393-016-0088-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatoid arthritis (RA) is the most common chronic inflammatory joint disease with a prevalence of up to 1 % in the adult population. This study describes the prevalence of RA diagnoses in outpatient health insurance claims data, based on different case definitions and stratified by age, sex and region of residence. Based on data from a nationwide statutory health insurance fund (BARMER GEK) from the year 2013, a cross-sectional study of insurants aged 18 years or older was conducted. The following case definitions were applied: A) a diagnosis of seropositive rheumatoid arthritis (M05) or other rheumatoid arthritis (M06) according to the international classification of diseases 10 German modification (ICD-10-GM) in at least two quarterly periods of the year 2013, B) case definition A plus determination of CaEuroreactive protein (CRP) or erythrocyte sedimentation rate (ESR) at least once, C) case definition B plus specific drug therapy and D) case definition A plus treatment by a rheumatologist. Raw as well as age and sex-standardized prevalences were calculated and stratified according to the federal state. The study population consisted of 7,155,315 insurants of whom 60.2 % were female. Overall, RA prevalences for the respective case definitions were 1.62 % (A), 1.11 % (B), 0.94 % (C) and 0.64 % (D). When standardized to the German population the prevalences were 1.38 % (A), 0.95 % (B), 0.81 % (C) and 0.55 % (D). The proportion of women was approximately 80 % for all case definitions. Prevalences increased with age, peaking in the age group 70-79 years old and showing the highest values in eastern and the lowest in southern Germany for raw as well as standardized measures. Regional differences in the prevalence of RA diagnoses in health insurance claims data were observed independent of age, sex and case definition. The expected prevalence according to the results of international studies was best achieved when case definitions with CRP or ESR were considered.
引用
收藏
页码:819 / 826
页数:8
相关论文
共 42 条
  • [31] Sex and Gender Differences in Environmental Influences on Dementia Incidence in Germany, 2014-2019: An Observational Cohort Study Based on Health Claims Data
    Kreft, Daniel
    Doblhammer, Gabriele
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 87 (01) : 223 - 237
  • [32] High prevalence of breast cancer in light polluted areas in urban and rural regions of South Korea: An ecologic study on the treatment prevalence of female cancers based on National Health Insurance data
    Kim, Yun Jeong
    Lee, Eunil
    Lee, Hyo Sun
    Kim, Mari
    Park, Man Sik
    CHRONOBIOLOGY INTERNATIONAL, 2015, 32 (05) : 657 - 667
  • [33] Risk of cancer, cardiovascular disease, thromboembolism, and mortality in patients with rheumatoid arthritis receiving Janus kinase inhibitors: a real-world retrospective observational study using Korean health insurance data
    Min, Hong Ki
    Kim, Hyeongsu
    Jeong, Ho Jin
    Kim, Se Hee
    Kim, Hae-Rim
    Lee, Sang-Heon
    Lee, KunSei
    Shin, Soon-Ae
    Park, Jong Heon
    EPIDEMIOLOGY AND HEALTH, 2023, 45 : 1 - 10
  • [34] Prevalence of HIV infection among non-elderly individuals with hepatitis C in Japan: a population-based cohort study using a health insurance claim data
    Ikeuchi, Kazuhiko
    Okushin, Kazuya
    Saito, Makoto
    Adachi, Eisuke
    Tsutsumi, Takeya
    Takura, Tomoyuki
    Yotsuyanagi, Hiroshi
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [35] Regional differences in the prevalence of known Type 2 diabetes mellitus in 45-74 years old individuals: Results from six population-based studies in Germany (DIAB-CORE Consortium)
    Schipf, S.
    Werner, A.
    Tamayo, T.
    Holle, R.
    Schunk, M.
    Maier, W.
    Meisinger, C.
    Thorand, B.
    Berger, K.
    Mueller, G.
    Moebus, S.
    Bokhof, B.
    Kluttig, A.
    Greiser, K. H.
    Neuhauser, H.
    Ellert, U.
    Icks, A.
    Rathmann, W.
    Voelzke, H.
    DIABETIC MEDICINE, 2012, 29 (07) : E88 - E95
  • [36] Prevalence of type 1 and type 2 diabetes in children and adolescents in Germany from 2002 to 2020: A study based on electronic health record data from the DPV registry
    Stahl-Pehe, Anna
    Kamrath, Clemens
    Prinz, Nicole
    Kapellen, Thomas
    Menzel, Ulrike
    Kordonouri, Olga
    Schwab, K. Otfried
    Bechtold-Dalla Pozza, Susanne
    Rosenbauer, Joachim
    Holl, Reinhard W.
    JOURNAL OF DIABETES, 2022, 14 (12) : 840 - 850
  • [37] Compression or expansion of dementia in Germany? An observational study of short-term trends in incidence and death rates of dementia between 2006/07 and 2009/10 based on German health insurance data
    Doblhammer, Gabriele
    Fink, Anne
    Zylla, Stephanie
    Willekens, Frans
    ALZHEIMERS RESEARCH & THERAPY, 2015, 7
  • [38] Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany—a health insurance claims data analysis; [Therapiepersistenz unter realen Bedingungen bei Patienten mit rheumatoider Arthritis nach Beginn einer DMARD-Therapie – eine Analyse von Abrechnungsdaten der Krankenversicherungen in Deutschland]
    Fiehn C.
    Zinke S.
    Haas J.S.
    Meise D.
    Theil J.
    Gurrath M.
    Orzechowski H.-D.
    Zeitschrift für Rheumatologie, 2023, 82 (9) : 739 - 753
  • [39] Indirect costs of absenteeism due to rheumatoid arthritis, psoriasis, multiple sclerosis, insulin-dependent diabetes mellitus, and ulcerative colitis in 2012: a study based on real-life data from the Social Insurance Institution in Poland
    Malinowski, Krzysztof Piotr
    Kawalec, Pawel Piotr
    Mocko, Pawel
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (02) : 295 - 303
  • [40] Increased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a retrospective longitudinal population-based study using the Japanese health insurance database
    Sakai, Ryoko
    Tanaka, Eiichi
    Inoue, Eisuke
    Harigai, Masayoshi
    RMD OPEN, 2024, 10 (02):